Context Therapeutics (CNTX) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Context Therapeutics (CNTX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: December 5, 2024 (14:56)

Sector: Healthcare

The share price of Context Therapeutics Inc. (CNTX) now

Latest session on the 4th of December for
Context Therapeutics Inc. is negative
Trading Volume: 48747
Open: 1.51 /  High: 1.57 /  Low: 1.475
What analysts predict: $7.7
52-week High/Low: $2.75 / $0.79
50-Day Moving Average: $1.931 — resistance level today
200-Day Moving Average: $1.846 — resistance level today

Are you interested in Context Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Context Therapeutics stock price in 2025, 2026, 2027. How much will one Context Therapeutics share be worth in 2025 - 2027?

When should I take profit in Context Therapeutics stock? When should I record a loss on Context Therapeutics stock? What are analysts' forecasts for Context Therapeutics stock? What is the future of Context Therapeutics stock? We forecast Context Therapeutics stock performance using neural networks based on historical data on Context Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Context Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Context Therapeutics shares. This happens once a day.


Historical and forecast chart of Context Therapeutics stock

The chart below shows the historical price of Context Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Context Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Context Therapeutics is a clinical-stage American biotechnology company that develops drugs for the treatment of cancer in women. In particular, the therapeutic focus of the company’s candidate drugs is directed towards breast cancer as well as gynecological oncology. In the clinical stage, Context Therapeutics has two directions: it is a drug for the prevention and treatment of ovarian, endometrial and breast cancer ONA-XR and the Claudin 6 program, which is a stage for the study of a bispecific monoclonal antibody against CD3 x anti-Claudin 6 (CLDN6) antigen ( bsAbs).

Trending Themes in the Healthcare Sector

Context Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 07 1.52 1.49 1.53 3.07
Dec 08 1.54 1.50 1.56 4.41
Dec 09 1.57 1.52 1.60 5.15
Dec 10 1.55 1.51 1.56 3.27
Dec 11 1.59 1.56 1.64 4.89
Dec 12 1.65 1.64 1.68 2.26
Dec 13 1.63 1.60 1.64 3.06
Dec 14 1.64 1.61 1.68 3.91
Dec 15 1.61 1.58 1.63 3.52
Dec 16 1.60 1.58 1.65 4.21
Dec 17 1.56 1.52 1.60 4.73
Dec 18 1.56 1.52 1.59 5.16
Dec 19 1.62 1.58 1.66 5.26
Dec 20 1.67 1.65 1.70 2.54
Dec 21 1.73 1.68 1.75 4.20
Dec 22 1.72 1.70 1.76 3.57
Dec 23 1.74 1.69 1.78 5.18
Dec 24 1.71 1.67 1.73 3.77
Dec 25 1.72 1.71 1.77 3.95
Dec 26 1.73 1.68 1.74 3.92
Dec 27 1.75 1.72 1.80 4.81
Dec 28 1.72 1.71 1.76 3.19
Dec 29 1.75 1.71 1.78 4.09
Dec 30 1.72 1.70 1.74 2.39
Dec 31 1.78 1.74 1.82 4.74
Jan 01 1.78 1.72 1.80 4.58
Jan 02 1.75 1.71 1.79 4.83
Jan 03 1.70 1.69 1.75 3.55
Jan 04 1.68 1.66 1.70 2.79
Jan 05 1.70 1.67 1.73 3.54

Context Therapeutics Daily Price Targets


Context Therapeutics Stock Forecast 12-07-2024.

Forecast target price for 12-07-2024: $1.52.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 2.975%.
Pessimistic target level: 1.49
Optimistic target level: 1.53

Context Therapeutics Stock Forecast 12-08-2024.

Forecast target price for 12-08-2024: $1.54.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 4.226%.
Pessimistic target level: 1.50
Optimistic target level: 1.56

Context Therapeutics Stock Forecast 12-09-2024.

Forecast target price for 12-09-2024: $1.57.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 4.902%.
Pessimistic target level: 1.52
Optimistic target level: 1.60

Context Therapeutics Stock Forecast 12-10-2024.

Forecast target price for 12-10-2024: $1.55.
Negative dynamics for Context Therapeutics shares will prevail with possible volatility of 3.168%.
Pessimistic target level: 1.51
Optimistic target level: 1.56

Context Therapeutics Stock Forecast 12-11-2024.

Forecast target price for 12-11-2024: $1.59.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 4.660%.
Pessimistic target level: 1.56
Optimistic target level: 1.64

Context Therapeutics Stock Forecast 12-12-2024.

Forecast target price for 12-12-2024: $1.65.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 2.209%.
Pessimistic target level: 1.64
Optimistic target level: 1.68

CNTX (CNTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan. 1.49 1.26 1.65 23.47
Feb. 1.55 1.32 1.63 19.16
Mar. 1.47 1.41 1.63 13.41
Apr. 1.47 1.27 1.53 17.05
May. 1.20 1.02 1.30 22.14
Jun. 1.33 1.23 1.47 16.27
Jul. 1.25 1.14 1.38 17.09
Aug. 1.22 1.16 1.36 14.70
Sep. 1.11 0.96 1.26 23.54
Oct. 1.22 1.15 1.35 15.16
Nov. 1.04 0.96 1.17 18.09
Dec. 1.05 0.91 1.16 22.02

Context Therapeutics forecast for this year


Context Therapeutics Stock Prediction for Jan 2025

An downtrend is forecast for this month with an optimal target price of $1.48584. Pessimistic: $1.26. Optimistic: $1.65


Context Therapeutics Stock Prediction for Feb 2025

An uptrend is forecast for this month with an optimal target price of $1.55122. Pessimistic: $1.32. Optimistic: $1.63


Context Therapeutics Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $1.47366. Pessimistic: $1.41. Optimistic: $1.63


Context Therapeutics Stock Prediction for Apr 2025

An downtrend is forecast for this month with an optimal target price of $1.46776. Pessimistic: $1.27. Optimistic: $1.53


Context Therapeutics Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $1.20356. Pessimistic: $1.02. Optimistic: $1.30


Context Therapeutics Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $1.33114. Pessimistic: $1.23. Optimistic: $1.47


Context Therapeutics Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $1.25394. Pessimistic: $1.14. Optimistic: $1.38


Context Therapeutics Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $1.21632. Pessimistic: $1.16. Optimistic: $1.36


Context Therapeutics Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $1.11171. Pessimistic: $0.96. Optimistic: $1.26


Context Therapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $1.21844. Pessimistic: $1.15. Optimistic: $1.35


Context Therapeutics Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $1.04055. Pessimistic: $0.96. Optimistic: $1.17


Context Therapeutics Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $1.05095. Pessimistic: $0.91. Optimistic: $1.16



Context Therapeutics (CNTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 1.08 1.03 1.18 13.14
Feb 1.04 0.92 1.14 19.13
Mar 0.96 0.87 1.07 18.13
Apr 0.88 0.77 0.97 20.26
May 0.91 0.86 0.96 10.34
Jun 0.88 0.84 0.97 13.85
Jul 0.93 0.89 1.00 11.46
Aug 0.90 0.77 0.97 20.56
Sep 0.75 0.64 0.83 23.19
Oct 0.68 0.64 0.73 11.82
Nov 0.68 0.58 0.75 22.56
Dec 0.63 0.57 0.70 18.30

Context Therapeutics (CNTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.72 0.67 0.82 17.96
Feb 0.77 0.65 0.81 19.73
Mar 0.80 0.75 0.83 10.17
Apr 0.65 0.56 0.74 23.62
May 0.65 0.58 0.74 21.62
Jun 0.62 0.57 0.69 16.70
Jul 0.65 0.55 0.74 25.57
Aug 0.60 0.58 0.65 11.44
Sep 0.66 0.62 0.77 19.66
Oct 0.78 0.74 0.85 13.44
Nov 0.88 0.81 0.95 15.24
Dec 0.98 0.91 1.11 17.73

Context Therapeutics information and performance

Context Therapeutics Address

3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA, US

Market Capitalization: 113 247 000 $

Market capitalization of the Context Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CNTX shares in the company outstanding by the market price of one share.

EBITDA: -20 014 956 $

EBITDA of Context Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.88

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 1.597

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 74998000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.